Patients with NAFLD had a pro-atherosclerotic lipid profile characterized by high triglyceride, elevated very low-density lipoprotein (VLDL), high apolipoprotein B (ApoB) to apolipoprotein AI (ApoAI) ratio, and low levels of HDL, which lead to an increased CVD risk (110). This evidence concerns the gene APOB and metabolic dysfunction-associated steatotic liver disease.